154 related articles for article (PubMed ID: 31676217)
1. [Benefit of elective percutaneous coronary intervention for stable coronary artery disease].
Ennezat PV; Malergue MC; Czitrom D; Maréchaux S; Tricot O; Le Jemtel TH; Vincentelli A
Presse Med; 2019 Oct; 48(10):1037-1042. PubMed ID: 31676217
[No Abstract] [Full Text] [Related]
2. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.
Rihal CS; Raco DL; Gersh BJ; Yusuf S
Circulation; 2003 Nov; 108(20):2439-45. PubMed ID: 14623791
[No Abstract] [Full Text] [Related]
3. The State of Percutaneous Intervention in Stable Coronary Artery Disease.
Drescher C; Rao SV
Curr Atheroscler Rep; 2020 Jul; 22(8):42. PubMed ID: 32671483
[TBL] [Abstract][Full Text] [Related]
4. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
Li Q; Deng SB; Xia S; Du JL; She Q
Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
[TBL] [Abstract][Full Text] [Related]
5. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
6. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
[TBL] [Abstract][Full Text] [Related]
7. [Role of percutaneous coronary intervention in diabetic patients].
Gencer B; Noble S; Bonvini RF; Mach F; Roffi M
Rev Med Suisse; 2013 May; 9(388):1137-8, 1140-1. PubMed ID: 23789182
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
Escaned J; Collet C; Ryan N; De Maria GL; Walsh S; Sabate M; Davies J; Lesiak M; Moreno R; Cruz-Gonzalez I; Hoole SP; Ej West N; Piek JJ; Zaman A; Fath-Ordoubadi F; Stables RH; Appleby C; van Mieghem N; van Geuns RJ; Uren N; Zueco J; Buszman P; Iñiguez A; Goicolea J; Hildick-Smith D; Ochala A; Dudek D; Hanratty C; Cavalcante R; Kappetein AP; Taggart DP; van Es GA; Morel MA; de Vries T; Onuma Y; Farooq V; Serruys PW; Banning AP
Eur Heart J; 2017 Nov; 38(42):3124-3134. PubMed ID: 29020367
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
10. Impact of C-Reactive Protein and Coronary Artery Calcium on Benefit Observed With Atorvastatin.
Blaha MJ; Nasir K; Budoff MJ; Dardari ZA; Blumenthal RS; Pollack S; Reichek N; Guerci AD
J Am Coll Cardiol; 2018 May; 71(21):2487-2488. PubMed ID: 29793637
[No Abstract] [Full Text] [Related]
11. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
Pöss J; Böhm M; Laufs U
Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
[TBL] [Abstract][Full Text] [Related]
12. CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease.
Nicolini F; Agostinelli A; Vezzani A; Benassi F; Gherli T
Int Heart J; 2014; 55(6):469-73. PubMed ID: 25297505
[TBL] [Abstract][Full Text] [Related]
13. Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.
Kassimis G; Patel N; Banning AP
Curr Pharm Des; 2014; 20(28):4589-96. PubMed ID: 24568733
[TBL] [Abstract][Full Text] [Related]
14. Statins and contrast-induced acute kidney injury with coronary angiography.
Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
[TBL] [Abstract][Full Text] [Related]
15. Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.
Kumar A; Shariff M; Doshi R
Eur J Prev Cardiol; 2020 Dec; 27(19):2138-2141. PubMed ID: 31382809
[No Abstract] [Full Text] [Related]
16. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
Patti G; Pasceri V; Nusca A; Di Sciascio G
Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary interventions and statins therapy.
Nusca A; Melfi R; Di Sciascio G
Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):101-7. PubMed ID: 19124413
[TBL] [Abstract][Full Text] [Related]
18. Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective.
Williams ME
Clin J Am Soc Nephrol; 2006 Mar; 1(2):209-20. PubMed ID: 17699209
[No Abstract] [Full Text] [Related]
19. Interpreting the COURAGE trial. PCI is no better than medical therapy for stable angina? Seeing is not believing.
Kereiakes DJ
Cleve Clin J Med; 2007 Sep; 74(9):637-8, 640-2. PubMed ID: 17879517
[No Abstract] [Full Text] [Related]
20. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
